Arkolith/Insider Trading/RYTM/Form 4

German Christopher Paul

Corporate Controller & CAORHYTHM PHARMACEUTICALS, INC. (RYTM) · full profile →Form 4 · filed May 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$428K
Net Open-Market Flow
-$428K
Transactions
7
4 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2026Option exercise(M)2K$56.69$96K2K
May 15, 2026Option exercise(M)1K$49.23$66K3K
May 15, 2026Option exercise(M)1K$17.97$25K5K
May 15, 2026Sell(S)5K$92.21$428K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 15, 2026Option exercise(M)2K—$04K
May 15, 2026Option exercise(M)1K—$03K
May 15, 2026Option exercise(M)1K—$02K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-063830) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML